Ovarian cancer immunotherapy found to boost immune response
IMNN-001, Imunon’s experimental immunotherapy for advanced ovarian cancer,…
Gynecological cancer encompasses a group of cancers affecting the female reproductive system. Approximately 100,000 people are diagnosed with gynecological cancer in the U.S. every year. Although each type of gynecological cancer is unique, with its own symptoms, risk factors, and treatment options, reaching an early diagnosis is critical for ensuring the best possible outcomes in any of them.
Read moreThere are several treatment approaches for gynecological cancer, which encompasses all cancers that originate in the female reproductive system. The choice of treatment will depend on the cancer type, how far it has spread, a patient’s general health status, and other factors, such as whether the patient wishes for their fertility to be preserved.
Read moreIMNN-001, Imunon’s experimental immunotherapy for advanced ovarian cancer,…
A Phase 3 clinical trial of Enhertu, a…
Relacorilant lowered the risk of disease progression and death…
Pheast Therapeutics has received fast track designation from the…
Treatment with pembrolizumab — an immune-modulating therapy sold for…
The use of testosterone as part of gender-affirming care…